Stay updated on Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T13:48:49.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a new field labeled 'Last Update Posted (Estimated)' on the Study Details page and removed the previous 'Last Update Posted' field.
    Difference
    0.0%
    Check dated 2025-10-27T10:47:16.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.
    Difference
    2%
    Check dated 2025-10-06T04:21:59.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Core terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and page revision incremented from v3.0.2 to v3.1.0, indicating an updated version of the page.
    Difference
    0.1%
    Check dated 2025-09-28T23:37:16.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    - Updated page revision from v3.0.1 to v3.0.2, signaling a new patch-level update to the core content. - Removed the 'Back to Top' element, a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-14T09:55:10.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T07:33:24.000Z thumbnail image

Stay in the know with updates to Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.